Literature DB >> 29878141

What Can We Learn From Menstrual Patterns After Treatment for HER2-Positive Breast Cancer?

Elizabeth Cathcart-Rake1, Kelly C Gast2, Kathryn J Ruddy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 29878141      PMCID： PMC7962886          DOI： 10.1093/jnci/djy092

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  26 in total

Review 1.  Prevention of chemotherapy-induced ovarian damage.

Authors:  Hadassa Roness; Oren Kashi; Dror Meirow
Journal:  Fertil Steril       Date:  2015-12-08       Impact factor: 7.329

Review 2.  Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review.

Authors:  Jessica Howard-Anderson; Patricia A Ganz; Julienne E Bower; Annette L Stanton
Journal:  J Natl Cancer Inst       Date:  2012-01-23       Impact factor: 13.506

3.  Prospective study of fertility concerns and preservation strategies in young women with breast cancer.

Authors:  Kathryn J Ruddy; Shari I Gelber; Rulla M Tamimi; Elizabeth S Ginsburg; Lidia Schapira; Steven E Come; Virginia F Borges; Meghan E Meyer; Ann H Partridge
Journal:  J Clin Oncol       Date:  2014-02-24       Impact factor: 44.544

4.  Adjuvant ovarian suppression in premenopausal breast cancer.

Authors:  Prudence A Francis; Meredith M Regan; Gini F Fleming
Journal:  N Engl J Med       Date:  2015-04-23       Impact factor: 91.245

5.  The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.

Authors:  Aytac Yuksel; Gamze Bildik; Filiz Senbabaoglu; Nazli Akin; Macit Arvas; Fehmi Unal; Yagmur Kilic; Isil Karanfil; Baldan Eryılmaz; Pelin Yilmaz; Can Ozkanbaş; Cagatay Taskiran; Senai Aksoy; Yılmaz Guzel; Basak Balaban; Umit Ince; Akira Iwase; Bulent Urman; Ozgur Oktem
Journal:  Hum Reprod       Date:  2015-10-13       Impact factor: 6.918

6.  What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis.

Authors:  Jianli Zhao; Jieqiong Liu; Kai Chen; Shunrong Li; Ying Wang; Yaping Yang; Heran Deng; Weijuan Jia; Nanyan Rao; Qiang Liu; Fengxi Su
Journal:  Breast Cancer Res Treat       Date:  2014-03-27       Impact factor: 4.872

Review 7.  Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

Authors:  Janice M Walshe; Neelima Denduluri; Sandra M Swain
Journal:  J Clin Oncol       Date:  2006-11-27       Impact factor: 44.544

8.  Menses resumption after cancer treatment-induced amenorrhea occurs early or not at all.

Authors:  Melanie H Jacobson; Ann C Mertens; Jessica B Spencer; Amita K Manatunga; Penelope P Howards
Journal:  Fertil Steril       Date:  2015-12-01       Impact factor: 7.329

9.  Cancer and fertility preservation: international recommendations from an expert meeting.

Authors:  Matteo Lambertini; Lucia Del Mastro; Maria C Pescio; Claus Y Andersen; Hatem A Azim; Fedro A Peccatori; Mauro Costa; Alberto Revelli; Francesca Salvagno; Alessandra Gennari; Filippo M Ubaldi; Giovanni B La Sala; Cristofaro De Stefano; W Hamish Wallace; Ann H Partridge; Paola Anserini
Journal:  BMC Med       Date:  2016-01-04       Impact factor: 8.775

10.  Ovarian function after chemotherapy in young breast cancer survivors.

Authors:  K Morarji; O McArdle; K Hui; G Gingras-Hill; S Ahmed; E M Greenblatt; E Warner; S Sridhar; A M F Ali; A Azad; D C Hodgson
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.